BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23137583)

  • 1. Comparative safety of therapies in systemic lupus erythematosus.
    Mosak J; Furie R
    Rheum Dis Clin North Am; 2012 Nov; 38(4):795-807. PubMed ID: 23137583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical therapy for systemic lupus erythematosus.
    Taylor JK; McMurray RV
    J Miss State Med Assoc; 2011 Feb; 52(2):39-43. PubMed ID: 21387869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of systemic lupus erythematosus: Facts and controversies.
    Elbirt D; Sthoeger D; Asher I; Sthoeger ZM
    Clin Dermatol; 2010; 28(3):330-6. PubMed ID: 20541688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging biological therapies in systemic lupus erythematosus.
    Mount GR; Gilliland WR
    Clin Pharmacol Ther; 2008 Jan; 83(1):167-71. PubMed ID: 18000515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M; Jones RJ; Brodsky RA
    Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of antimalarials in systemic lupus erythematosus.
    Esdaile JM
    Lupus; 1993 Feb; 2 Suppl 1():S3-8. PubMed ID: 8485568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of antimalarials in systemic lupus erythematosus.
    Nayak V; Esdaile JM
    Lupus; 1996 Jun; 5 Suppl 1():S23-7. PubMed ID: 8803906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment. Disease-modifying therapies.
    Lieberman JD; Schatten S
    Rheum Dis Clin North Am; 1988 Apr; 14(1):223-43. PubMed ID: 3041490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Diagnosis and Treatment of Systemic Lupus Erythematosus.
    Kuhn A; Bonsmann G; Anders HJ; Herzer P; Tenbrock K; Schneider M
    Dtsch Arztebl Int; 2015 Jun; 112(25):423-32. PubMed ID: 26179016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
    J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine A in the long-term management of systemic lupus erythematosus.
    Germano V; Picchianti Diamanti A; Ferlito C; Podestà E; Salemi S; Migliore A; D' Amelio R; Laganà B
    J Biol Regul Homeost Agents; 2011; 25(3):397-403. PubMed ID: 22023764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of medication use before, during and after pregnancy in women with systemic lupus erythematosus: a population-based cohort study.
    Zusman EZ; Sayre EC; Aviña-Zubieta JA; De Vera MA
    Lupus; 2019 Sep; 28(10):1205-1213. PubMed ID: 31311418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
    Merrill JT; Wallace DJ; Petri M; Kirou KA; Yao Y; White WI; Robbie G; Levin R; Berney SM; Chindalore V; Olsen N; Richman L; Le C; Jallal B; White B;
    Ann Rheum Dis; 2011 Nov; 70(11):1905-13. PubMed ID: 21798883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population.
    Hardy C; Gladman DD; Su J; Rozenbojm N; Urowitz MB
    Rheumatol Int; 2021 Aug; 41(8):1457-1464. PubMed ID: 34089358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication use in systemic lupus erythematosus.
    Bernatsky S; Peschken C; Fortin PR; Pineau CA; Urowitz MB; Gladman DD; Pope JE; Hudson M; Zummer M; Smith CD; Arbillaga HO; Clarke AE;
    J Rheumatol; 2011 Feb; 38(2):271-4. PubMed ID: 21078722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aggressive therapy of highly active systemic lupus erythematosus].
    Graninger W
    Acta Med Austriaca; 1996; 23(4):129-33. PubMed ID: 9036724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents.
    Dooley MA; Ginzler EM
    Rheum Dis Clin North Am; 2006 Feb; 32(1):91-102, ix. PubMed ID: 16504823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and prognosis of systemic lupus erythematosus.
    Dubois EL
    Bull Rheum Dis; 1967 Nov; 18(3):477-82. PubMed ID: 4868664
    [No Abstract]   [Full Text] [Related]  

  • 19. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
    Pusongchai T; Jungthirapanich J; Khositseth S
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Insights Into Systemic Lupus Erythematosus Therapies: 2010-2020.
    Wang DH; Wallace DJ
    J Clin Rheumatol; 2022 Jan; 28(1):e217-e221. PubMed ID: 33065630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.